Mirati Therapeutics Stock Price, News & Analysis (OTCMKTS:MYLGF)

$6.07 0.00 (0.00 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$6.07
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume355 shs
Market Capitalization$70.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Mirati Therapeutics (OTCMKTS:MYLGF)

MethylGene, Inc. operates as a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics for cancer and infectious disease.

Receive MYLGF News and Ratings via Email

Sign-up to receive the latest news and ratings for MYLGF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:MYLGF
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Mirati Therapeutics (OTCMKTS:MYLGF) Frequently Asked Questions

What is Mirati Therapeutics' stock symbol?

Mirati Therapeutics trades on the OTCMKTS under the ticker symbol "MYLGF."

Who are some of Mirati Therapeutics' key competitors?

Who are Mirati Therapeutics' key executives?

Mirati Therapeutics' management team includes the folowing people:

  • Martin Godbout Ph.D, Chairman of the Board (Age 57)
  • Charles M. Baum M.D., Ph.D., President, Chief Executive Officer, Director (Age 55)
  • Mark J. Gergen, Chief Operations Officer, Executive Vice President (Age 51)
  • Rachel W. Humphrey M.D., Chief Medical Officer, Executive Vice President (Age 51)
  • Jamie A. Donadio, Vice President - Finance (Age 38)
  • Henry J. Fuchs M.D., Ph.D., Independent Director (Age 55)
  • Rodney W. Lappe Ph.D., Independent Director (Age 58)
  • Peter A. Thompson M.D., Independent Director (Age 53)

How do I buy Mirati Therapeutics stock?

Shares of Mirati Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mirati Therapeutics' stock price today?

One share of Mirati Therapeutics stock can currently be purchased for approximately $6.07.

How big of a company is Mirati Therapeutics?

Mirati Therapeutics has a market capitalization of $70.20 million.


MarketBeat Community Rating for Mirati Therapeutics (MYLGF)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  128
MarketBeat's community ratings are surveys of what our community members think about Mirati Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mirati Therapeutics (OTCMKTS:MYLGF) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Mirati Therapeutics (OTCMKTS:MYLGF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Mirati Therapeutics (OTCMKTS:MYLGF) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Mirati Therapeutics (OTCMKTS:MYLGF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (OTCMKTS MYLGF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Mirati Therapeutics (OTCMKTS MYLGF) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Mirati Therapeutics (OTCMKTS:MYLGF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Mirati Therapeutics (OTCMKTS MYLGF) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.